Showing results (61-70 of 147) with videos related to
Sort By:
Pageof 15
Journal of Clinical Pharmacology|August 16, 2005
Concomitant tacrolimus and micafungin pharmacokinetics in healthy volunteersMary F Hebert, David K Blough, Robert W Townsend, et al.Life Sciences|March 31, 2023
Plasma hydrogen sulfide, nitric oxide, and thiocyanate levels are lower during pregnancy compared to postpartum in a cohort of women from the Pacific northwest of the United StatesMaxwell B Zeigler, Emily E Fay, Sue L Moreni, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 1998
Tamoxifen in liver disease: potential exacerbation of hepatic dysfunctionL C Floren, M F Hebert, A P Venook, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 24, 2010
CYP2D6 mediates 4-hydroxylation of clonidine in vitro: implication for pregnancy-induced changes in clonidine clearanceAdam J Claessens, Linda J Risler, Sara Eyal, et al.Research Communications in Molecular Pathology and Pharmacology|December 22, 1999
Insulin stimulation of glutamine: fructose-6-phosphate amidotransferase occurs via an insulin-like growth factor-1 pathway in rat fibroblastsS T Simmons, M C Daniels, E Huddleston, et al.Life Sciences|October 18, 2020
Changes in erythrocyte membrane epoxyeicosatrienoic, dihydroxyeicosatrienoic, and hydroxyeicosatetraenoic acids during pregnancySelina T Somani, Maxwell Zeigler, Emily E Fay, et al.British Journal of Clinical Pharmacology|March 29, 2012
The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometricsJ G Coen van Hasselt, Marilee A Andrew, Mary F Hebert, et al.Endocrinology|September 21, 2001
Antagonists of GHRH decrease production of GH and IGF-I in MXT mouse mammary cancers and inhibit tumor growthK Szepeshazi, A V Schally, P Armatis, et al.Pharmacoepidemiology and Drug Safety|March 1, 2018
Patterns of prednisone use during pregnancy in women with rheumatoid arthritis: Daily and cumulative doseKristin Palmsten, Matthieu Rolland, Mary F Hebert, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 28, 2006
Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitroYang Dai, Mary F Hebert, Nina Isoherranen, et al.Pageof 15